Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling

Fig. 1

Effect of ZBC260 on BET protein expression and TNBC cell viability. a–d Kaplan–Meier survival curves of basal breast cancer patients based on BRD2, BRD3, BRD4, and overall expression of BET proteins. e Representative immunoblot of lysate from SUM149 and SUM159 cells treated with ZBC260. Protein expression was normalized to β-Actin where n = 3 independent experiments

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us